Epithelial metaplasia: An inadequate environment for antitumour immunity?

Trends in Immunology

Volumn 25, Issue 4, 2004, Pages 169-173

  Delvenne, Philippe ^a   Hubert, Pascale ^a   Jacobs, Nathalie ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE RECEPTOR CCR5; CYCLOOXYGENASE 2; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; PROSTAGLANDIN; RANTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UVOMORULIN;

ANTIGEN PRESENTING CELL; CARCINOGENESIS; CHRONIC INFLAMMATION; DENDRITIC CELL; EMBRYOLOGY; EPITHELIUM; ESOPHAGUS; EXTRACELLULAR MATRIX; GENE EXPRESSION; HELPER CELL; HUMAN; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; METAPLASIA; METHYLATION; MUCOSA; NONHUMAN; PATHOGENESIS; PROMOTER REGION; RESPIRATORY SYSTEM; REVIEW; STOMACH; TRANSGENIC MOUSE; TUMOR IMMUNITY; UTERINE CERVIX;

EID: 1642374081     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2004.02.002     Document Type: Article

References (51)

1. Marincola F.M., et al. Tumors as elusive targets of T-cell-based active immunotherapy. Trends Immunol. 24:2003;335-342.
2. Mantovani A., et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23:2002;549-555.
3. Uchi H., et al. Cytokines and chemokines in the epidermis. J. Dermatol. Sci. 24:(Suppl 1):2000;S29-S38.
4. Seitz C.S., et al. Alterations in NF-κB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-κB. Proc. Natl. Acad. Sci. U. S. A. 95:1998;2307-2312.
5. Takeda K., et al. Limb and skin abnormalities in mice lacking IKKα Science. 284:1999;313-316.
6. Thomas R.S., et al. ETS1, NF-κB and AP1 synergistically transactivate the human GM-CSF promoter. Oncogene. 14:1997;2845-2855.
7. Mocellin S., et al. The dual role of IL-10. Trends Immunol. 24:2003;36-43.
8. Lentsch A.B., et al. In vivo suppression of NF-κB and preservation of IκB α by interleukin-10 and interleukin-13. J. Clin. Invest. 100:1997;2443-2448.
9. Giannini S.L., et al. Cytokine expression in squamous intraepithelial lesions of the uterine cervix: implications for the generation of local immunosuppression. Clin. Exp. Immunol. 113:1998;183-189.
10. Jacobs N., et al. Distinct T cell subsets and cytokine production in cultures derived from transformation zone and squamous intraepithelial lesion biopsies of the uterine cervix. Am. J. Reprod. Immunol. 49:2003;6-13.
11. Fitzgerald R.C., et al. Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut. 50:2002;451-459.
12. Al-Saleh W., et al. Correlation of T-helper secretory differentiation and types of antigen-presentating cells in squamous intraepithelial lesions of the uterine cervix. J. Pathol. 184:1998;283-290.
13. Dabbagh K., et al. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J. Immunol. 162:1999;6233-6237.
14. Hodge S., et al. Up-regulation of production of TGF-β and IL-4 and down-regulation of IL-6 by apoptotic human bronchial epithelial cells. Immunol. Cell Biol. 80:2002;537-543.
15. Lee C.G., et al. Transgenic overexpression of interleukin (IL)-10 in the lung causes mucus metaplasia, tissue inflammation, and airway remodeling via IL-13-dependent and -independent pathways. J. Biol. Chem. 277:2002;35466-35474.
16. Zissel G., et al. Regulation of cytokine release by alveolar macrophages treated with interleukin-4, interleukin-10, or transforming growth factor β Eur. Cytokine Netw. 7:1996;59-66.
17. Romberger D.J., et al. Modulation of fibronectin production of bovine bronchial epithelial cells by transforming growth factor-β Am. J. Respir. Cell Mol. Biol. 7:1992;149-155.
18. Farthing M.J., et al. Acid, helicobacter and immunity: a new paradigm for oesophagogastric cancer. J. Physiol. (Paris). 95:2001;423-427.
19. Al-Saleh W., et al. Inverse modulation of intraepithelial Langerhans cells and stromal macrophage populations in human papillomavirus-associated squamous intraepithelial lesions of the cervix. Virchows Arch. 427:1995;41-48.
20. Giannini S.L., et al. Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Int. J. Cancer. 97:2002;654-659.
21. Woltman A.M., van Kooten C. Functional modulation of dendritic cells to suppress adaptive immune responses. J. Leukoc. Biol. 73:2003;428-441.
22. Caux C., et al. Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin. Immunopathol. 22:2000;345-369.
23. Bejarano M.T., et al. Interleukin 10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures. Int. Immunol. 4:1992;1389-1397.
24. + T cells resulting in a failure to lyse tumor cells. Blood. 93:1999;1634-1642.
25. Wang B., et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 162:1999;277-283.
26. Qin Z., et al. Interleukin-10 prevents dendritic cell accumulation and vaccination with granulocyte-macrophage colony-stimulating factor gene-modified tumor cells. J. Immunol. 159:1997;770-776.
27. Ludewig B., et al. Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40-ligand) and TNF-α, but strongly enhanced by interleukin-10. Eur. J. Immunol. 25:1995;1943-1950.
28. Wira C.R., Rossoll R.M. Oestradiol regulation of antigen presentation by uterine stromal cells: role of transforming growth factor-β production by epithelial cells in mediating antigen-presenting cell function. Immunology. 109:2003;398-406.
29. Kanda N., Watanabe S. 17β-estradiol inhibits MCP-1 production in human keratinocytes. J. Invest. Dermatol. 120:2003;1058-1066.
30. Remoue F., et al. High intraepithelial expression of oestrogen and progesterone receptors in the transformation zone of the uterine cervix. Am. J. Obstet. Gynecol. 189:2003;1660-1665.
31. Kang G.H., et al. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res. 61:2001;2847-2851.
32. Khandaker M.H., et al. Metalloproteinases are involved in lipopolysaccharide- and tumor necrosis factor-α-mediated regulation of CXCR1 and CXCR2 chemokine receptor expression. Blood. 93:1999;2173-2185.
33. Mota F., et al. The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium. Clin. Exp. Immunol. 116:1999;33-40.
34. Hoglund P., et al. The uterine cervix - a new member of the family of immunologically exceptional sites? Cancer Immun. 3:2003;6.
35. Morris C.D., et al. Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Am. J. Gastroenterol. 96:2001;990-996.
36. van Rees B.P., et al. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J. Pathol. 196:2002;171-179.
37. Shirvani V.N., et al. Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: Ex vivo induction by bile salts and acid exposure. Gastroenterology. 118:2000;487-496.
38. Hilkens C.M., et al. Differential modulation of T helper type 1 (Th1) and T helper type 2 (Th2) cytokine secretion by prostaglandin E2 critically depends on interleukin-2. Eur. J. Immunol. 25:1995;59-63.
39. Zeidler R., et al. Tumor cell-derived prostaglandin E2 inhibits monocyte function by interfering with CCR5 and Mac-1. FASEB J. 14:2000;661-668.
40. Yang L., et al. Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. J. Clin. Invest. 111:2003;727-735.
41. Kalinski P., et al. Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer. Blood. 97:2001;3466-3469.
42. Ikai K., Imamura S. Prostaglandin D2 in the skin. Int. J. Dermatol. 27:1988;141-149.
43. Hammad H., et al. Prostaglandin D2 inhibits airway dendritic cell migration and function in steady state conditions by selective activation of the D prostanoid receptor 1. J. Immunol. 171:2003;3936-3940.
44. Jiang X.H., Wong B.C. Cyclooxygenase-2 inhibition and gastric cancer. Curr. Pharm. Des. 9:2003;2281-2288.
45. Tang A., et al. Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin. Nature. 361:1993;82-85.
46. Cepek K.L., et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin. Nature. 372:1994;190-193.
47. Smedts F., et al. Detection of keratin subtypes in routinely processed cervical tissue: implications for tumour classification and the study of cervix cancer aetiology. Virchows Arch. 425:1994;145-155.
48. Chan A.O., et al. Deregulation of E-cadherin-catenin complex in precancerous lesions of gastric adenocarcinoma. J. Gastroenterol. Hepatol. 18:2003;534-539.
49. Swami S., et al. E-cadherin expression in gastroesophageal reflux disease, Barrett's esophagus, and esophageal adenocarcinoma: an immunohistochemical and immunoblot study. Am. J. Gastroenterol. 90:1995;1808-1813.
50. Tselepis C., et al. Tumour necrosis factor-α in Barrett's oesophagus: a potential novel mechanism of action. Oncogene. 21:2002;6071-6081.
51. Chan A.O., et al. Promoter methylation of E-cadherin gene in gastric mucosa associated with Helicobacter pylori infection and in gastric cancer. Gut. 52:2003;502-506.